EMAIL THIS PAGE TO A FRIEND

Journal of the science of food and agriculture

Dietary L-arginine modulates immunosuppression in broilers inoculated with an intermediate strain of infectious bursa disease virus.


PMID 24728981

Abstract

The effects of dietary l-arginine (Arg) on immunosuppression following infectious bursal disease virus (IBDV) inoculation in broiler chickens were evaluated. The design of this study was a 5 × 2 factorial arrangement (n = 5) with five Arg concentrations (starter: 9.9, 13.9, 17.6, 21.3 and 25.3 g kg(-1) ; grower-finisher: 9.5, 13.5, 17.1, 20.1 and 23.6 g kg(-1) ) with or without IBDV inoculation (IBDV or saline inoculation at 14 days). Chickens were sampled at 2, 4 and 6 days post-inoculation (DPI) and 42 days of age. The IBDV inoculation decreased (P = 0.05) CD3(+) , CD4(+) , and CD8(+) T cell counts at 2 days post-inoculation (DPI) and monocyte counts at 6 DPI; and reduced (P < 0.05) bursal interleukin-1β (IL-1β) mRNA expression at 2 DPI and serum IL-6 concentration at 4 DPI. Increasing Arg concentration increased (P < 0.05) CD4(+) and CD8(+) T cell counts at 2 DPI, linearly increased (P = 0.05) CD3(+) T cell counts in IBDV-inoculated groups and monocyte counts in control groups at 4 DPI; increased (P < 0.05) serum IL-6 concentration in IBDV-inoculated groups at 2 DPI; and increased (P < 0.05) serum anti-IBDV antibody titres at 42 days of age. Varying concentrations of Arg supplementation attenuated IBDV inoculation induced immunosuppression via modulating circulating T cell sub-populations.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

T3251
(±)-α-Tocopherol, synthetic, ≥96% (HPLC)
C29H50O2
90669
(±)-α-Tocopherol, tested according to Ph.Eur.
C29H50O2
47783
(±)-α-Tocopherol, analytical standard
C29H50O2
T3634
(+)-α-Tocopherol, from vegetable oil, Type V, ~1000 IU/g
C29H50O2
T1539
(+)-α-Tocopherol, Type VI, from vegetable oil, neat (liquid, ≥0.88M based on potency, density and molecular wt.), BioReagent, suitable for insect cell culture, ≥1000 IU/g
C29H50O2
R4500
(−)-Riboflavin, from Eremothecium ashbyii, ≥98%
C17H20N4O6
R7649
(−)-Riboflavin, meets USP testing specifications
C17H20N4O6
R0508
(−)-Riboflavin, acrylamide photopolymerization tested
C17H20N4O6
R9504
(−)-Riboflavin, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥98%
C17H20N4O6
T1550000
α-Tocopherol, European Pharmacopoeia (EP) Reference Standard
C29H50O2
258024
α-Tocopherol, ≥95.5%
C29H50O2
PHR1031
Alpha Tocopherol, Pharmaceutical Secondary Standard; Certified Reference Material
C29H50O2
1667600
Alpha Tocopherol, United States Pharmacopeia (USP) Reference Standard
C29H50O2
C9756
Cholecalciferol, ≥98% (HPLC)
C27H44O
C9774
Cholecalciferol, analytical standard
C27H44O
C1357
Cholecalciferol, meets USP testing specifications
C27H44O
C2100000
Cholecalciferol, European Pharmacopoeia (EP) Reference Standard
C27H44O
1131009
Cholecalciferol, United States Pharmacopeia (USP) Reference Standard
C27H44O
47763
Cholecalciferol (D3), analytical standard
C27H44O
PHR1237
Cholecalciferol (Vitamin D3), Pharmaceutical Secondary Standard; Certified Reference Material
C27H44O
C2150000
Cholecalciferol for system suitability, European Pharmacopoeia (EP) Reference Standard
C27H44O
C7527
Choline chloride, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥98%
C5H14ClNO
C7017
Choline chloride, ≥99%
C5H14ClNO
1133547
Choline chloride, United States Pharmacopeia (USP) Reference Standard
C5H14ClNO
C1879
Choline chloride, ≥98%
C5H14ClNO
26978
Choline chloride, BioUltra, ≥99.0% (AT)
C5H14ClNO
PHR1251
Choline chloride, Pharmaceutical Secondary Standard; Certified Reference Material
C5H14ClNO
C3607
Cyanocobalamin, meets USP testing specifications
C63H88CoN14O14P
43107
Cyanocobalamin, tested according to Ph.Eur.
C63H88CoN14O14P
C3000000
Cyanocobalamin, European Pharmacopoeia (EP) Reference Standard
C63H88CoN14O14P